Portfolio company
map-pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops inhaled therapies for neurological and respiratory conditions, such as migraines and asthma, for patients requiring systemic or targeted drug delivery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Miist Therapeutics
This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
Aquilon Pharma
This company develops inhaled and nasal medicines and formulation technologies for patients with respiratory disorders such as asthma and chronic obstructive pulmonary disease.
Softhale
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
Civitas Therapeutics
This biopharmaceutical company develops inhaled drug delivery technologies for patients with neurological disorders such as Parkinson's disease.
Kinaset Therapeutics
This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.
Alexza Pharmaceuticals
This company develops inhalation-based therapies for acute central nervous system conditions, providing rapid treatment for patients with psychiatric and neurological disorders.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
